Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals Revenue

Regeneron Pharmaceuticals had revenue of $3.72B in the quarter ending September 30, 2024, with 10.65% growth. This brings the company's revenue in the last twelve months to $13.85B, up 5.72% year-over-year. In the year 2023, Regeneron Pharmaceuticals had annual revenue of $13.12B with 7.76% growth.

• Revenue (ttm): $13.85B
• Revenue Growth: +5.72%
• P/S Ratio: 5.55
• Revenue / Employee: $1,029,524
• Employees: 13,450
• Market Cap: 76.89B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	13.12B	944.30M	7.76%
Dec 31, 2022	12.17B	-3.90B	-24.26%
Dec 31, 2021	16.07B	7.57B	89.14%
Dec 31, 2020	8.50B	1.94B	29.58%
Dec 31, 2019	6.56B	1.41B	27.44%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.